新关注 > 信息聚合 > 外媒头条:制药巨头在华行贿被美证监会罚款

外媒头条:制药巨头在华行贿被美证监会罚款

Foreign media headlines: pharmaceutical giant bribery in China by the CSRC

2016-09-01 06:03:13来源: 新浪

MarketWatch 阿斯利康涉华行贿被罚550万美元 美国证监会(SEC)周三宣布,制药巨头阿斯利康同意支付550万美元,以了结针对其中国与俄罗斯子公司涉嫌行贿问题进行的调查。SEC表示,...

MarketWatch astrazeneca China bribery was fined $5.5 million The securities and exchange commission (SEC) announced on Wednesday that the pharmaceutical giant astrazeneca agreed to pay $5.5 million, to settle on its subsidiary China and Russia to investigation of bribery issues. The SEC said,...